<?xml version='1.0' encoding='utf-8'?>
<document id="25424246"><sentence text="Drug-drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different CYP2C8 Genotypes."><entity charOffset="30-38" id="DDI-PubMed.25424246.s1.e0" text="Losartan" /><entity charOffset="43-53" id="DDI-PubMed.25424246.s1.e1" text="Paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s1.e0" e2="DDI-PubMed.25424246.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s1.e0" e2="DDI-PubMed.25424246.s1.e1" /></sentence><sentence text="The cytochrome P450 (CYP) 2C8*3 allele is associated with reduced metabolic activity of paclitaxel"><entity charOffset="88-98" id="DDI-PubMed.25424246.s2.e0" text="paclitaxel" /></sentence><sentence text=" This study was aimed to investigate the inhibitory effect of losartan on paclitaxel metabolism in human liver microsomes (HLMs) and to determine the impact of the CYP2C8*3 polymorphism"><entity charOffset="62-70" id="DDI-PubMed.25424246.s3.e0" text="losartan" /><entity charOffset="74-84" id="DDI-PubMed.25424246.s3.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s3.e0" e2="DDI-PubMed.25424246.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s3.e0" e2="DDI-PubMed.25424246.s3.e1" /></sentence><sentence text=" HLMs that contained the CYP2C8*1 homozygote (HL60) or CYP2C8*3 heterozygote (HL54) genotype were used for the inhibition study" /><sentence text=" Losartan, at a concentration of 50 μmol/L, significantly inhibited paclitaxel metabolism by 29% and 57% in the HL60 (p &lt; 0"><entity charOffset="1-9" id="DDI-PubMed.25424246.s5.e0" text="Losartan" /><entity charOffset="68-78" id="DDI-PubMed.25424246.s5.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s5.e0" e2="DDI-PubMed.25424246.s5.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s5.e0" e2="DDI-PubMed.25424246.s5.e1" /></sentence><sentence text="001) and HL54 (p &lt; 0" /><sentence text="01), respectively" /><sentence text=" When using HL60, losartan and the CYP3A4-selective inhibitors, erythromycin and ketoconazole, caused a greater inhibition of the paclitaxel metabolism than quercetin, a CYP2C8-selective inhibitor"><entity charOffset="12-16" id="DDI-PubMed.25424246.s8.e0" text="HL60" /><entity charOffset="18-26" id="DDI-PubMed.25424246.s8.e1" text="losartan" /><entity charOffset="64-76" id="DDI-PubMed.25424246.s8.e2" text="erythromycin" /><entity charOffset="81-93" id="DDI-PubMed.25424246.s8.e3" text="ketoconazole" /><entity charOffset="130-140" id="DDI-PubMed.25424246.s8.e4" text="paclitaxel" /><entity charOffset="157-166" id="DDI-PubMed.25424246.s8.e5" text="quercetin" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e1" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e0" e2="DDI-PubMed.25424246.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e1" e2="DDI-PubMed.25424246.s8.e1" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e1" e2="DDI-PubMed.25424246.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e1" e2="DDI-PubMed.25424246.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e1" e2="DDI-PubMed.25424246.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e1" e2="DDI-PubMed.25424246.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e2" e2="DDI-PubMed.25424246.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e2" e2="DDI-PubMed.25424246.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e2" e2="DDI-PubMed.25424246.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e2" e2="DDI-PubMed.25424246.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e3" e2="DDI-PubMed.25424246.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e3" e2="DDI-PubMed.25424246.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e3" e2="DDI-PubMed.25424246.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e4" e2="DDI-PubMed.25424246.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25424246.s8.e4" e2="DDI-PubMed.25424246.s8.e5" /></sentence><sentence text=" This demonstrated that the paclitaxel metabolism was mainly catalysed by CYP3A4 in HL60"><entity charOffset="28-38" id="DDI-PubMed.25424246.s9.e0" text="paclitaxel" /><entity charOffset="84-93" id="DDI-PubMed.25424246.s9.e1" text="HL60" /><pair ddi="false" e1="DDI-PubMed.25424246.s9.e0" e2="DDI-PubMed.25424246.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s9.e0" e2="DDI-PubMed.25424246.s9.e1" /></sentence><sentence text=" There were no significant differences found for the inhibitory effects caused by the four inhibitors of the paclitaxel metabolism in HL54, indicating that both CYP2C8 and CYP3A4 play important roles in paclitaxel metabolism in HL54"><entity charOffset="109-119" id="DDI-PubMed.25424246.s10.e0" text="paclitaxel" /><entity charOffset="203-213" id="DDI-PubMed.25424246.s10.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s10.e0" e2="DDI-PubMed.25424246.s10.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s10.e0" e2="DDI-PubMed.25424246.s10.e1" /></sentence><sentence text=" These findings suggest that 50 μmol/L of losartan inhibits both CYP2C8 and CYP3A4 in HLMs"><entity charOffset="42-50" id="DDI-PubMed.25424246.s11.e0" text="losartan" /></sentence><sentence text=" In summary, losartan inhibited paclitaxel metabolism, with concentrations over 50 μmol/L in HLMs"><entity charOffset="13-21" id="DDI-PubMed.25424246.s12.e0" text="losartan" /><entity charOffset="32-42" id="DDI-PubMed.25424246.s12.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s12.e0" e2="DDI-PubMed.25424246.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s12.e0" e2="DDI-PubMed.25424246.s12.e1" /></sentence><sentence text=" The CYP2C8*3 allele carriers are likely susceptible to the interactions of losartan and CYP3A4 inhibitors to paclitaxel metabolism"><entity charOffset="76-84" id="DDI-PubMed.25424246.s13.e0" text="losartan" /><entity charOffset="110-120" id="DDI-PubMed.25424246.s13.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.25424246.s13.e0" e2="DDI-PubMed.25424246.s13.e0" /><pair ddi="false" e1="DDI-PubMed.25424246.s13.e0" e2="DDI-PubMed.25424246.s13.e1" /></sentence><sentence text="" /></document>